BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 17299390)

  • 1. Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma.
    Ford CE; Lau SK; Zhu CQ; Andersson T; Tsao MS; Vogel WF
    Br J Cancer; 2007 Mar; 96(5):808-14. PubMed ID: 17299390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of discoidin domain receptor 2 (DDR2): a novel independent prognostic marker of worse outcome in breast cancer patients.
    Ren T; Zhang J; Zhang J; Liu X; Yao L
    Med Oncol; 2013 Mar; 30(1):397. PubMed ID: 23307244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discoidin domain receptors: a promoter of the aggressive behavior of ameloblastomas.
    Yang J; Liu J; Zhong M; Chen Y; Song M; Du Y
    IUBMB Life; 2014 Apr; 66(4):292-9. PubMed ID: 24723326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel driver mutations of the discoidin domain receptor 2 (DDR2) gene in squamous cell lung cancer of Chinese patients.
    Miao L; Wang Y; Zhu S; Shi M; Li Y; Ding J; Yang J; Ye Q; Cai H; Zhang D; Liu H; Song Y
    BMC Cancer; 2014 May; 14():369. PubMed ID: 24885564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung carcinomas.
    Yang SH; Baek HA; Lee HJ; Park HS; Jang KY; Kang MJ; Lee DG; Lee YC; Moon WS; Chung MJ
    Oncol Rep; 2010 Aug; 24(2):311-9. PubMed ID: 20596615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine kinase discoidin domain receptors DDR1 and DDR2 are coordinately deregulated in triple-negative breast cancer.
    Toy KA; Valiathan RR; Núñez F; Kidwell KM; Gonzalez ME; Fridman R; Kleer CG
    Breast Cancer Res Treat; 2015 Feb; 150(1):9-18. PubMed ID: 25667101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagen I induces discoidin domain receptor (DDR) 1 expression through DDR2 and a JAK2-ERK1/2-mediated mechanism in primary human lung fibroblasts.
    Ruiz PA; Jarai G
    J Biol Chem; 2011 Apr; 286(15):12912-23. PubMed ID: 21335558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of discoidin domain receptor 2 decreases tumor growth of hepatocellular carcinoma.
    Park JW; Lee YS; Kim JS; Lee SK; Kim BH; Lee JA; Lee NO; Kim SH; Hong EK
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):1973-83. PubMed ID: 25842034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitive methods for detection of the S768R substitution in exon 18 of the DDR2 gene in patients with central nervous system metastases of non-small cell lung cancer.
    Nicoś M; Powrózek T; Krawczyk P; Jarosz B; Pająk B; Sawicki M; Kucharczyk K; Trojanowski T; Milanowski J
    Med Oncol; 2014 Oct; 31(10):176. PubMed ID: 25173530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discoidin Domain Receptor-Driven Gene Signatures as Markers of Patient Response to Anti-PD-L1 Immune Checkpoint Therapy.
    You S; Kim M; Hoi XP; Lee YC; Wang L; Spetzler D; Abraham J; Magee D; Jain P; Galsky MD; Chan KS; Theodorescu D
    J Natl Cancer Inst; 2022 Oct; 114(10):1380-1391. PubMed ID: 35918812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NSCLC Driven by DDR2 Mutation Is Sensitive to Dasatinib and JQ1 Combination Therapy.
    Xu C; Buczkowski KA; Zhang Y; Asahina H; Beauchamp EM; Terai H; Li YY; Meyerson M; Wong KK; Hammerman PS
    Mol Cancer Ther; 2015 Oct; 14(10):2382-2389. PubMed ID: 26206333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of discoidin domain receptor 2 in A375 human melanoma cells reduces its experimental liver metastasis ability.
    Badiola I; Villacé P; Basaldua I; Olaso E
    Oncol Rep; 2011 Oct; 26(4):971-8. PubMed ID: 21701781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of collagen binding by the human discoidin domain receptors, DDR1 and DDR2. Identification of collagen binding sites in DDR2.
    Leitinger B
    J Biol Chem; 2003 May; 278(19):16761-9. PubMed ID: 12611880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of discoidin domain receptor 2 in nasopharyngeal carcinoma.
    Chua HH; Yeh TH; Wang YP; Huang YT; Sheen TS; Lo YC; Chou YC; Tsai CH
    Head Neck; 2008 Apr; 30(4):427-36. PubMed ID: 18023033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The D2 period of collagen II contains a specific binding site for the human discoidin domain receptor, DDR2.
    Leitinger B; Steplewski A; Fertala A
    J Mol Biol; 2004 Dec; 344(4):993-1003. PubMed ID: 15544808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new target for therapy in squamous cell carcinoma of the lung.
    Ohashi K; Pao W
    Cancer Discov; 2011 Jun; 1(1):23-4. PubMed ID: 22586316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A host deficiency of discoidin domain receptor 2 (DDR2) inhibits both tumour angiogenesis and metastasis.
    Zhang S; Bu X; Zhao H; Yu J; Wang Y; Li D; Zhu C; Zhu T; Ren T; Liu X; Yao L; Su J
    J Pathol; 2014 Mar; 232(4):436-48. PubMed ID: 24293323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of discoidin domain receptors in rat kidney.
    Lee R; Eidman KE; Kren SM; Hostetter TH; Segal Y
    Nephron Exp Nephrol; 2004; 97(2):e62-70. PubMed ID: 15218324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intracellular juxtamembrane domain of discoidin domain receptor 2 (DDR2) is essential for receptor activation and DDR2-mediated cancer progression.
    Kim D; Ko P; You E; Rhee S
    Int J Cancer; 2014 Dec; 135(11):2547-57. PubMed ID: 24740739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel insights into the role of Discoidin domain receptor 2 (DDR2) in cancer progression: a new avenue of therapeutic intervention.
    Trono P; Ottavi F; Rosano' L
    Matrix Biol; 2024 Jan; 125():31-39. PubMed ID: 38081526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.